August 2026 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-...

New research article First nationwide full-genome characterisation of human-derived #AndesVirus in Chile: a retrospective genomic epidemiology study www.thelancet.com/journals/lan... #IDSky #ClinMicro #ViroSky #hantavirus #OpenAccess #OA

In a secondary analysis of the BALANCE randomized clinical trial, 7 days of antibiotics was not associated with increased mortality compared to 14 days among patients with uncomplicated bloodstream infection. ja.ma/4vTJNiz

📣 In the July 2026 issue: Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort study www.clinicalmicrobiologyandinfection.org/article/S119... #covid #IDSky #MicroSky

🎙️ Just published Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened Hosted by Angela Huttner & Josh Davis w/ guests Prof Brett Mitchell, Aline Wolfensberger & Lauren Clack #IDSky #clinmicro Listen on #Communicable: https://share.transistor.fm/s/825e18f4

💥🆕 “Sepsis -Beyond the guidelines” Critical Matters podcast 👇Free Access bit.ly/4vWCmaA @unmc.bsky.social @unmc-id.bsky.social @unmccom.bsky.social @critcaremed.bsky.social @criticalcarereviews.com #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #meded #Pharmsky #MicroSky #ClinMicro

💥🆕 “Sepsis -Beyond the guidelines” Critical Matters podcast 👇Free Access bit.ly/4vWCmaA @unmc.bsky.social @unmc-id.bsky.social @unmccom.bsky.social @critcaremed.bsky.social @criticalcarereviews.com #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #meded #Pharmsky #MicroSky #ClinMicro

New genomic data suggest the ongoing #Bundibugyo virus outbreak arose from a single zoonotic spillover, with the outbreak lineage likely emerging weeks before detection—underscoring the critical role of genomic surveillance for early outbreak detection and response. virological.org/t/genomic-ep...

📣New #Communicable drops Mon 13 July! Angela Huttner & Josh Davis are joined by Prof Brett Mitchell#Communicable Aline Wolfensberger & Lauren Clack to discuss the HAPPEN trial, a multicentre RCT showing impressive reductions in hospital-acquired #pneumonia, and the studies that led to it.🎙️ #IDSky #clinmicro

Considering where to publish your next study? JAMA Network Open offers rapid online publication, broad dissemination, extensive media attention, and an Impact Factor of 11.7—all designed to maximize the visibility and impact of your research. Learn more: ja.ma/4ftmoOf

📣 New Supplement publication in CMI The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the #EUCAST Subcommittee @escmid.bsky.social Read here: www.clinicalmicrobiologyandinfection.org/article/S119...

🌟 The 2025 JCR Impact Factor for CMI has risen to 8.7! We thank our editors, reviewers, authors and readers for their dedication and extraordinary work. Read about how CMI did in 2025 here: clinicalmicrobiologyandinfection.org/article/S119... #IDSky #MicroSky #JIF #JCR2025

Excited to share our latest publication in AIDS! We performed one of the largest multi-ancestry genome-wide association studies of cardiovascular disease in people living with HIV using the Million Veteran Program. We identified a novel genetic locus near NAT8 associated with CVD risk.

#VisualAbstract Appropriate empirical antimicrobial therapy was independently associated with reduced 28-day mortality in critically ill ICU patients with microbiologically confirmed bacterial infections. zurl.co/UBMt4

Bayesian Thinking in the Intensive Care Unit: From Statistical Theory to Clinical Practice CCR Journal Watch https://criticalcarereviews.com/latest-evidence/journal-watch

How to use lactate levels to guide septic shock resuscitation: an update CCR Journal Watch https://criticalcarereviews.com/latest-evidence/journal-watch

Great to see our new paper out in Nature Communications. In it we describe three novel phenotypes in lungs of patients with pneumonia. Pn1 -a non-neutrophil driven lung injury phenotype, Pn2-a balanced immune response with best recovery and Pn3-persistent inflammation driven by immature neutrophils

Join us! @idsainfo.bsky.social immunocompromised host COP’s virtual town hall will be on 6/26— 1 pm EST. Please refer to the email or the myIDSA page for info. @pergamic.bsky.social @emilymeich.bsky.social @arunasubramanian.bsky.social @pearliechong.bsky.social #Andrea_Zimmer @paulksue1.bsky.social

🎙️ A special bonus episode of #Communicable is coming Monday Angela Huttner & Anne-Grete Märtson talk with Daniel Bausch & Martin Grobusch on how #Bundibugyo ebolavirus differs from Zaire & what to expect in the current outbreak #IDSky #Virosky #clinmicro https://ow.ly/nm5250Z7ViE

Congrats to my colleagues for this interesting analysis. Looking at patients who met DOTS criteria and receive dalbavancin in our hospital, they differ from the DOTS trial Younger, more IDU, more R-sided IE (less SSTI), and more persistent bacteremia. Yet, outcomes similar #IDSky

In clinical practice, patients with #Bacteremia receiving dalbavancin were younger and more likely to have substance use or housing instability than those in the DOTS trial, but completed therapy with similar low failure rates. ja.ma/4odctAk

In this latest @escmid.bsky.social clinical guideline, a panel of 16 multidisciplinary experts provide recommendations for how to evaluate and manage patients with reported antibiotic allergies. www.clinicalmicrobiologyandinfection.org/article/S119...

The Emerging Infections Subcommittee just published in CMI a rapid assessment of the Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda, covering the current situation and key challenges. https://ow.ly/rS5s50Z60wO

Alveolar dysregulation of host response in pneumonia and ARDS: implications for immune modulation and infection CCR Journal Watch https://criticalcarereviews.com/latest-evidence/journal-watch

🎙️ Just published Communicable E54: ESCMID Global Late Breakers, part 2 Hosted by our editors - Erin McCreary, PharmD, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner 🌟 Listen on #Communicable: https://share.transistor.fm/s/a8cc04bb#Communicable #ESCMIDGlobal2026 #IDSky #clinmicro

📣 New publication: First reported case of Andes hantavirus cardiopulmonary syndrome treated with a combination of favipiravir, ribavirin, icatibant and baricitinib: www.clinicalmicrobiologyandinfection.org/article/S119... #hantavirus

Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee @cmijournal.bsky.social @escmid.bsky.social www.clinicalmicrobiologyandinfection.org/article/S119...

New editorial Key facts about the Bundibugyo virus outbreak www.thelancet.com/journals/lan...

Rapid Microbiological Diagnostics for Sepsis: Narrative Review of Current and Prospective Approaches CCR Journal Watch https://criticalcarereviews.com/latest-evidence/journal-watch

Thanks to @oriolmitja.bsky.social for writing this for us Andes virus on a cruise ship: person-to-person transmission and an empty pipeline

💥🆕”Can Influenza Virus Cause Bacteremia, Sepsis, and Septic Shock?” Out today 👇Free bit.ly/3PWNDYu @unmc-id.bsky.social @criticalcarereviews.com #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky#ClinMicro @cidjournal.bsky.social @cmijournal.bsky.social @cmicomms.bsky.social @kcawcutt.bsky.social

𝗣𝘂𝗯𝗹𝗶𝗰 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝗹𝗲𝗿𝘁𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: This report details an investigation into the recent hantavirus outbreak on the 𝘔𝘝 𝘏𝘰𝘯𝘥𝘪𝘶𝘴 cruise ship, including clinical details, case timeline, genetic sequencing of the virus, and unresolved questions about viral transmission. Full report: https://nej.md/4uQDeMQ

📣 New publication: Andes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment www.clinicalmicrobiologyandinfection.org/article/S119...

For those needing a one article summary of events-this is it! www.clinicalmicrobiologyandinfection.org/article/S119... #cmi #idposts

📣 New #Communicable drops Mon, 18 May! Our editors - Erin McCreary, PharmD, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner #Communicable- discuss some of the Late Breaker trials that caught their attention at #ESCMIDGlobal2026, and whether results will change their practice🎙️ #IDSky #clinmicro

💥🆕”Andes hantavirus outbreak on a cruise ship-an ESCMID(EIS) rapid assessment” 👇Free Access bit.ly/3P1Tbkh @unmccom.bsky.social @unmc-id.bsky.social @cmijournal.bsky.social @cmicomms.bsky.social @jesusrbano.bsky.social #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #MicroSky #ClinMicro

Our collaboration episode with Breakpoints covering the trials from the ESCMID Global session 'The trial run' is out now! share.transistor.fm/s/e2a9aee4 🎙️✨ @erinmccreary.bsky.social @gurujosh.bsky.social @jesusrbano.bsky.social #IDSky #clinmicro

“The Year in Clinical Micro” at #ESCMIDGlobal2026 Gram-negatives are the biggest AMR threat: ⚠️ >40% E. coli & 55% K. pneumoniae resistant to 3rd-gen cephalosporins 📊 ~1/3 UTIs already resistant 📈 ⬆️ resistance across GI infections & gonorrhea Without global action, AMR deaths could ⬆️ ~70% by 2050

Looking forward to seeing you at this exciting ESCMID Late-breaking session on Sunday 👇👇 @escmid.bsky.social @cmijournal.bsky.social @cmicomms.bsky.social @unmc-id.bsky.social #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #TxID #meded #Pharmsky #Pharmed #RXSky #MicroSky #ClinMicro

Looking forward to seeing you at this exciting ESCMID Late-breaking session on Sunday 👇👇 @escmid.bsky.social @cmijournal.bsky.social @cmicomms.bsky.social @unmc-id.bsky.social #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #TxID #meded #Pharmsky #Pharmed #RXSky #MicroSky #ClinMicro

@drandrekalil.bsky.social & Dr. Scherger co-authored an @annalsofim.bsky.social Journal Club on sepsis immunotherapy! #IDSky www.acpjournals.org/doi/10.7326/...

💥🆕 Inhaled Antibiotics for Ventilator-Associated Pneumonia: Is It Ready for Prime Time? Our new article is out 👇 bit.ly/48GgLt7 @unmc-id.bsky.social @critcaremed.bsky.social @criticalcarereviews.com #IDSky #MedSky #PCCSky #ICUSky #EMIMCC #Ansky #EMSky #AMSSky #ClinMicro @cidjournal.bsky.social

ID Pharmacists Day is May 22!🎉 The theme, Beyond the Rx: ID Pharmacists as Educators & Advocates, highlights impact beyond optimizing regimens. Share how you or an ID Pharmacist you know has gone #BeyondTheRx on 5/22 for a chance to win a prize! @accpinfdprn.bsky.social sidp.org/idpharmacistsday

Learning from the best! Thank you to @cortes-penfield.bsky.social for visiting and teaching us about orthopedic infections and UTIs! #IDSky

🧪 Adults 50+ in Germany self-tested for 5 respiratory viruses to track community infections. SARS-CoV-2 had highest incidence, RSV caused longer illness & more doctor visits. Real-world insights for public health & vaccination strategies! www.clinicalmicrobiologyandinfection.org/article/S119...

📣 #Dengue is increasing everywhere: spreading to new geographic regions and on the rise in endemic regions. New concise clinical review by experts Lim and Chua, who share their expertise & experience. https://ow.ly/XkCa50YwanA#Dengue #IDSky #clinmicro #virosky #medsky #openaccess

April 2026 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-... #IDSky #MicroSky

Check out this new article on preventing SSIs via antibiotic prophylaxis in Anaesthesia Critical Care & Pain Medicine from @kcawcutt.bsky.social, Dr. Teran, Dr. Bergman and @drandrekalil.bsky.social #IDSky www.sciencedirect.com/science/arti...

💥🆕“Sepsis”.The Lancet Seminar Our new article 👇Free Access bit.ly/4aJIiKo @unmc.bsky.social @unmc-id.bsky.social @unmccom.bsky.social @critcaremed.bsky.social @criticalcarereviews.com @thelancet.com @thelancetinfdis.bsky.social@lancetrespirmed.bsky.social#IDSky #MedSky #PCCSky #ICUSky #Ansky #EMSky